Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Wiley Matthew T.

Over the trailing 90 days, Wiley Matthew T. (Other at Definium Therapeutics, Inc.) sold $129K of stock in DFTX, per 2 SEC Form 4 transactions.

Role
Other
Companies
DFTX
Window
Trailing 90 days · 2 transactions · CIK 1759703
Net activity
−$129K ($0 bought · $129K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
DFTXDefinium Therapeutics, Inc.2$129K−$129K

Transactions (2)

DateSymbolTypeSharesValueDescription
2026-06-25DFTXSell2.9K$129KOpen market or private sale
2026-06-22DFTXBuy62.5K$0Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Wiley's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free